CIK 0001321732 · Large accelerated filer
Penumbra Inc
Sign in to watch- Ticker
- PEN
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (510) 995-2486
- Business address
- ONE PENUMBRA PLACE, ALAMEDA, CA, 94502
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-02 | Roberts Johanna EVP, Gen. Counsel & Secretary | Sale 10b5-1 | −60 | $273.12 | $16K | 64,857 |
| 2025-09-02 | Grewal Harpreet Director | Sale 10b5-1 | −186 | $272.19 | $51K | 8,888 |
| 2025-08-20 | Elsesser Adam CEO and President | Option exercise 10b5-1 | +27,976 | $30.00 | $839K | 186,180 |
| 2025-08-20 | Elsesser Adam CEO and President | Sale 10b5-1 | −459 | $252.86 | $116K | 185,721 |
| 2025-08-20 | Elsesser Adam CEO and President | Sale 10b5-1 | −9,114 | $254.27 | $2.3M | 176,607 |
| 2025-08-20 | Elsesser Adam CEO and President | Sale 10b5-1 | −6,227 | $254.99 | $1.6M | 170,380 |
| 2025-08-20 | Elsesser Adam CEO and President | Sale 10b5-1 | −100 | $256.50 | $26K | 170,280 |
| 2025-08-20 | Elsesser Adam CEO and President | Option exercise · Stock Option (right to buy) 10b5-1 | −27,976 | 27,980 | ||
| 2025-08-15 | Yuen Maggie Chief Financial Officer | Option exercise 10b5-1 | +724 | $158.30 | $115K | 13,667 |
| 2025-08-15 | Yuen Maggie Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −724 | 5,376 | ||
| 2025-08-13 | Yuen Maggie Chief Financial Officer | Sale 10b5-1 | −2,000 | $250.00 | $500K | 12,943 |
| 2025-08-13 | Bose Arani Director | Sale 10b5-1 | −9,103 | $250.45 | $2.3M | 3,455 |
| 2025-08-13 | Bose Arani Director | Sale 10b5-1 | −2,897 | $251.27 | $728K | 558 |
| 2025-08-12 | Wilder Thomas Director | Sale 10b5-1 | −372 | $240.16 | $89K | 372 |
| 2025-08-11 | Roberts Johanna EVP, Gen. Counsel & Secretary | Sale 10b5-1 | −18 | $237.10 | $4K | 66,039 |
| 2025-08-11 | Roberts Johanna EVP, Gen. Counsel & Secretary | Sale 10b5-1 | −247 | $238.47 | $59K | 65,792 |
| 2025-08-11 | Roberts Johanna EVP, Gen. Counsel & Secretary | Sale 10b5-1 | −295 | $239.27 | $71K | 65,497 |
| 2025-08-11 | Roberts Johanna EVP, Gen. Counsel & Secretary | Sale 10b5-1 | −39 | $240.20 | $9K | 65,458 |
| 2025-08-11 | Roberts Johanna EVP, Gen. Counsel & Secretary | Sale 10b5-1 | −1 | $240.91 | $241 | 65,457 |
| 2025-08-06 | Elsesser Adam CEO and President | Option exercise 10b5-1 | +27,976 | $30.00 | $839K | 174,234 |
Page 6 of 54 · 1,063 trades